glp 1 bowel obstruction Adverse effects of GLP-1 class drugs. Gastrointestinal issues are Risk of Gastrointestinal Adverse Events

By increasing insulin secretion and reducing glucagon production, semaglutide GLP-1 helps lower blood sugar levels, which can be monitored through regular blood tests

In fasted healthy normal weight patients, GLP-1 (7-36) amide injection reduced fMRI activity induced by food images, in all brain areas studied (amygdala, insula, caudate, NAc, orbitofrontal cortex, and putamen), compared to saline injection [43]

doi: 10.3390/ijms21144852 237 BothunAMWoodsDC

Patients may experience gastrointestinal discomfort, including nausea, vomiting, or diarrhoea, especially during the initial phase of treatment

Gabery S, Salinas CG, Paulsen SJ, et al

others may want drugs that come with fewer side effects